Home
KYTHERA BIOPHARMACEUTICALS

KYTHERA BIOPHARMACEUTICALS Market Share Analysis for June 2026

Discover KYBELLA® (deoxycholic acid), the first and only FDA-approved injectable treatment to reduce fat under the chin.

Industry: N/A

Domainkythera.com

Year Founded2005

Employees51 - 200

Annual Revenue$1M - $2M

KYTHERA BIOPHARMACEUTICALS

KYTHERA BIOPHARMACEUTICALS (including company regionals)

kythera.com

See more website traffic and engagement information

KYTHERA BIOPHARMACEUTICALS Revenue up to June 2026 is 1M - 2M

revenue generated by KYTHERA BIOPHARMACEUTICALS top domains

KYTHERA BIOPHARMACEUTICALS top domains revenue over 3 years

Revenue for KYTHERA BIOPHARMACEUTICALS top domains

kythera.com1M - 2M

See more with Sales Intelligence

Total visits to KYTHERA BIOPHARMACEUTICALS's top domains

Understand KYTHERA BIOPHARMACEUTICALS market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in KYTHERA BIOPHARMACEUTICALS's top domains

Analyze KYTHERA BIOPHARMACEUTICALS engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on KYTHERA BIOPHARMACEUTICALS's top domains

See how KYTHERA BIOPHARMACEUTICALS keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

KYTHERA BIOPHARMACEUTICALS top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by KYTHERA BIOPHARMACEUTICALS

These are the website technologies, by industry, used by KYTHERA BIOPHARMACEUTICALS top domains

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

Domain Parking (1)

Domain Name Sales

Email Services (1)

Microsoft Exchange Online

More Technologies

2

See all

News & Signals from KYTHERA BIOPHARMACEUTICALS

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAllergan PLC acquires Kythera for $85M.Allergan (which markets Botox) not only acquired Kythera, it also just snagged Topokine for $85 million upfront, adding a new experimental treatment for eliminating bags under the eyes.